CenterHigh
WBAL Baltimore (Hearst)News report · Aug 26, 4:59 PM
FDA approves landmark pancreatic cancer drug that's shown to improve survival
The FDA approved a groundbreaking new drug for the most common form of pancreatic cancer.
← Today's headlines
9 sources checked · Left, Center, and Right included · 7m ago
Mostly Same
FDA approves landmark pancreatic cancer drug that's shown to improve survival
Chicago Sun-Times and Pittsburgh Tribune Review describe the same event in different terms.
3 Left4 Center2 Right
MOSTLY SAME
As of August 26, 2026 at 6:00 PM, this is how Optics News reads the wording differences in this story.
What happened The FDA approved a groundbreaking new drug for the most common form of pancreatic cancer.
The headline split The left frames it as "F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer". The right frames it as "FDA Approves 'Unprecedented' Pancreatic Cancer Drug".
Match confidence High confidence. 9 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceHigh
9 sources across Left, Center, and Right all describe the same event.
Framing confidenceMild
22/99 — small wording differences, not a major framing split.
WHAT EACH SIDE EMPHASIZED
Left / center-leftF.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
The New York Times · Center-left · News report
CenterFDA approves landmark pancreatic cancer drug that's shown to improve survival
WBAL Baltimore (Hearst) · Center · News report
Right / center-rightFDA Approves 'Unprecedented' Pancreatic Cancer Drug
Investor's Business Daily · Center-right · News report
SEE THE HEADLINES
Open source
Center-leftHigh
The New York TimesNews report · Aug 26, 6:00 PM
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Center-leftMostly Factual
NBC News - US NewsNews report · Aug 26, 5:56 PM
FDA approves groundbreaking new drug for pancreatic cancer
The Food and Drug Administration approved a groundbreaking new oral drug for pancreatic patients suffering from the most aggressive form of the disease. Daraxonrasib, which targets a mutati...
CenterHigh
The HillNews report · Aug 26, 5:50 PM
FDA approves groundbreaking new pancreatic cancer drug
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms...
CenterHigh
Courthouse NewsNews report · Aug 26, 5:16 PM
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
Pancreatic cancer is among the most deadly forms in large part because it is hard to detect before it starts spreading to other organs.
CenterMostly Factual
Washington's Top News (WTOP)News report · Aug 26, 4:36 PM
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective tre...
Show all 9 sources
Center-rightMostly Factual
Investor's Business DailyNews report · Aug 26, 4:18 PM
FDA Approves 'Unprecedented' Pancreatic Cancer Drug
Revolution Medicines won FDA approval Wednesday for the pancreatic cancer treatment that once caused its stock to skyrocket.
Center-rightMostly Factual
Pittsburgh Tribune ReviewNews report · Aug 26, 4:10 PM
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
WASHINGTON — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatmen...
Center-leftMostly Factual
Chicago Sun-TimesNews report · Aug 26, 4:05 PM
FDA approves landmark pancreatic cancer drug that's shown to improve survival
WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective tre...
Details22/99 Wording Gap · High confidence · 9 sources
22/99 Wording GapHigh confidence9 sources · 3 bias bucketsStable · 19 sources · all three buckets · comparable news formatFormats: News report
SOURCE MAP CHANGES
Aug 26, 4:05 PM: Chicago Sun-Times joined the source map.
Aug 26, 4:10 PM: Pittsburgh Tribune Review joined the source map.
Aug 26, 4:18 PM: Investor's Business Daily joined the source map.
Aug 26, 4:36 PM: Washington's Top News (WTOP) joined the source map.
Now: Wording Gap is 22/99 and story health is stable · 19 sources · all three buckets · comparable news format.